Search results
Results from the WOW.Com Content Network
The jury, in Delaware, agreed with Apple that previous iterations of Masimo's W1 and Freedom watches and chargers willfully violated Apple's patent rights in smartwatch designs.
This is a list of notable patent law cases in the United States in chronological order. The cases have been decided notably by the United States Supreme Court, the United States Court of Appeals for the Federal Circuit (CAFC) or the Board of Patent Appeals and Interferences (BPAI). While the Federal Circuit (CAFC) sits below the Supreme Court ...
Puma is no longer a plaintiff in the case. Tagrisso earned AstraZeneca nearly $5.8 billion in revenue last year, according to a company report. New York-based Pfizer, which acquired Wyeth in 2009 ...
The judge, who also made decisions over the calculation and payment of legal costs, said “something is going wrong” in a case where together the firms had spent an estimated £19 million.
Schillinger v. United States: 155 U.S. 163: 1894: Patent infringement claim against the United States cannot be asserted. Black Diamond Coal Mining Company v. Excelsior Coal Company: 156 U.S. 611: 1895: Consolidated Electric Light Co v. McKeesport Light Co: 159 U.S. 465: 1895: Risdon Iron & Locomotive Works v. Medart: 158 U.S. 68: 1895: Boyden ...
Patent and Trademark Office v. Booking.com B. V., 591 U.S. ___ (2020), was a United States Supreme Court case dealing with the trademarkability of a generic terms appended with a top-level domain (TLD) specifier (in this case "Booking.com"). The Court ruled that such names can be trademarked unless the existing combination of term and TLD is ...
Amgen Inc. v. Sanofi, 598 U.S. 594 (2023), is a United States Supreme Court case in which the Court held that Amgen's two patent applications on cholesterol-lowering drugs failed to satisfy the enablement clause of §112 of the Patent Act, 35 U.S.C. § 112(a).
Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013), was a Supreme Court case, which decided that "a naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated.” [1] However, as a "bizarre conciliatory prize" the Court allowed patenting of complementary DNA, which contains exactly the same protein-coding ...